Please click
 User   Pwd      Remember
Article Search: 
BiotechEast
· Home
· About us
· Services
· FAQ
· Contact us
Info Resources
· Companies
· Institutes
· Science parks
· Life science news
· Company spotlight
· Taiwan bio report
· Feature articles
· Asia-Pacific events
· Investment corner
· Technology transfer
· Int'l biotech links
· Info resources search
· Job listings
· Log out
Partners
1 2 3 4 5 6 7 8 9 10 ... Total pages:253  Next 

Life Science News

(Taiwan) Cancer communication cracked


(Taipei Times)

15 December, 2014
National Yang-Ming University and Taipei Veterans General Hospital recently unveiled a breakthrough finding that explains how cancer cells promote the recruitment of tumor-associated macrophages to remodel a tumor’s microenvironment to aid growth.
More...




Life Science News

(Taiwan) Price of MedeonBio stock triples after market debut


(Taipei Times)

15 December, 2014
Shares of Medeon Biodesign Inc (益安生醫), which makes medical devices for minimally invasive surgeries, tripled in value from Tuesday through Friday after its debut on the Emerging Stock Market, as investors have high hopes for its management team.
More...




Life Science News

(Taiwan) Taiwan and the Fight Against Ebola


(The Diplomat)

9 December, 2014
Taiwan's efforts to join the global fight against Ebola have gone relatively overlooked. In part, this is because Taiwan's participation is limited — not by choice, but by continuing restrictions on its engagement with international organizations at Beijing's insistence.
More...




Life Science News

(Taiwan) GNTbm updates status of partnership with China's Chipscreen for development of anti-cancer drug Chidamide


(BiotechEast staff)

12 December, 2014
Taiwan's Gold Nanotech Biotech & Medicals Corporation (GNTbm) held a press event in Taipei on 10 December to announce updates in the regulatory status for Chidamide, a novel oral selective histone deacetylase (HDAC) inhibitor for cancer licensed from Chipscreen Biosciences Ltd. of Shenzhen, China. Additionally, GNTbm took the opportunity to give updates to its pipeline of drugs developed in-house using gold nanoparticles as the drug delivery mechanism.




Life Science News

(Taiwan) Swissray to enter Taiwan's capital market


(China Post)

27 November, 2014
Swissray Global (Swissray) held the pre-IPO investor conference yesterday in Taipei and revealed it expects its listing on the GreTai Security Market (GTSM) in late December.
More...




Life Science News

(Taiwan) TaiGen applies to NHIA to set price for new drug


(Taipei Times)

25 November, 2014
Drugmaker TaiGen Biotechnology Co. yesterday said it submitted an application to the National Health Insurance Administration (NHIA) on Tuesday last week to set the price of a new antibiotic, with the hope that the company would be able to sell the drug in Taiwan within six months after receiving the administration’s approval.
More...




Life Science News

(Taiwan) Health services industry output on rise in Taiwan


(Taiwan Today)

27 November, 2014
Taiwan’s health and medical care services industry output is estimated to hit NT$26.4 billion (US$854.9 million) in 2014 and climb to NT$65 billion in 2017, according to Hsinchu City-based Industrial Technology Research Institute Nov. 25.
More...




Life Science News

(Taiwan) Gold NanoTech (GNT) introduces international wine and spirits partners


(BiotechEast staff)

27 November, 2014
Gold NanoTech Co., Ltd., (GNT), a Taipei, Taiwan-headquartered company focused on the production of gold nanoparticles for consumer and medical applications, held an international forum on Friday introducing its most recent 'Gold-in Alliance' international wine and spirits partners utilizing GNT gold in their products for the Taiwan and China markets.




Life Science News

(China) Genetically modified food: The sum of all China's fears


(The Interpreter)

25 November, 2014
Among the worries that keep Chinese leaders awake at night surely is food security. Li Keqiang's first priority upon taking the premiership in 2013 was agricultural modernisation. Civil rebellions and wars throughout China's history were fueled by the Malthusian need to keep people fed. As the nation now urbanises, the demands of keeping Chinese healthily nourished grow more acute. A spat over genetically modified (GM) food encapsulates the dilemma.
More...




Life Science News

(Taiwan) Biotech and ICT are the future for Taiwan industries


(WantChinaTimes.com)

25 November, 2014
Biotechnology and information and communication technology are projected to become Taiwan's next big industries, reports our Chinese-language sister newspaper Commercial Times.
More...




Sponsors

Events



Taiwan Life Sciences Bulletin

Enter email address to receive free e-newsletter


Sample

Disclaimer and Privacy Policy